(Q33937527)

30 July 2017

1 reference

title

Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics (English)

1 reference

30 July 2017

0 references

1 reference

Bearden DT

1

1 reference

30 July 2017

Rodvold KA

series ordinal

2

1 reference

30 July 2017

publication date

1 May 2000

1 reference

Clinical Pharmacokinetics

30 July 2017

published in

1 reference

30 July 2017

volume

38

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

415-426

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200038050-00003

30 July 2017

exact match

0 references

cites work

Should clearance be normalised to body surface or to lean body mass?

1 reference

12 December 2020

Therapeutic drug monitoring of vancomycin in a morbidly obese patient

1 reference

12 December 2020

Pharmacokinetic considerations in obesity

1 reference

12 December 2020

Disposition of cefotaxime and its desacetyl metabolite in morbidly obese male and female subjects.

1 reference

12 December 2020

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

1 reference

12 December 2020

Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms

1 reference

12 December 2020

Obesity as a risk factor in drug-induced organ injury. IV. Increased gentamicin nephrotoxicity in the obese overfed rat

1 reference

12 December 2020

Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Iohexol Cooperative Study Group.

1 reference

12 December 2020

Amikacin pharmacokinetics in morbidly obese patients undergoing gastric-bypass surgery

1 reference

12 December 2020

Single daily doses of aminoglycosides

1 reference

12 December 2020

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

12 December 2020

Pharmacokinetics of nafcillin in obesity

1 reference

12 December 2020

Routine monitoring of serum vancomycin concentrations: can waiting be justified?

1 reference

12 December 2020

Estimating creatinine clearance in morbidity obese patients

1 reference

12 December 2020

Estimation of creatinine clearance when urine cannot be collected.

1 reference

12 December 2020

A size standard for pharmacokinetics.

1 reference

12 December 2020

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

12 December 2020

Prophylactic cefazolin in gastric bypass surgery.

1 reference

12 December 2020

Fluconazole serum concentrations and pharmacokinetics in an obese patient

1 reference

12 December 2020

Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children

1 reference

12 December 2020

Effect of Obesity on Gentamicin Pharmacokinetics

1 reference

12 December 2020

Excessive aminoglycoside nephrotoxicity in obese patients

1 reference

12 December 2020

Lean body mass and volume of distribution

1 reference

12 December 2020

Intravenous ciprofloxacin dosing in a morbidly obese patient

1 reference

12 December 2020

Cefotiam disposition in markedly obese athlete patients, Japanese sumo wrestlers

1 reference

12 December 2020

Lean body mass as a predictor of drug dosage. Implications for drug therapy

1 reference

12 December 2020

Tobramycin pharmacokinetics in morbidly obese patients

1 reference

12 December 2020

Vancomycin Therapy in Patients with Impaired Renal Function: A Nomogram for Dosage

1 reference

12 December 2020

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

12 December 2020

Antibiotic prophylaxis for surgery in morbidly obese patients

1 reference

12 December 2020

Flucytosine dosing in an obese patient with extrameningeal cryptococcal infection.

1 reference

12 December 2020

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

12 December 2020

Vancomycin pharmacokinetics in normal and morbidly obese subjects

1 reference

12 December 2020

Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

12 December 2020

Amikacin pharmacokinetics in morbidly obese patients

1 reference

12 December 2020

Serum vancomycin concentrations: reappraisal of their clinical value

1 reference

12 December 2020

Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation

1 reference

12 December 2020

Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients

1 reference

12 December 2020

Prediction of creatinine clearance from serum creatinine

1 reference

12 December 2020

Administration o gentamicin to obese patients

1 reference

12 December 2020

Monitoring serum vancomycin levels: climbing the mountain because it is there?

1 reference

12 December 2020

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

12 December 2020

Prediction of apparent volume of distribution in obesity.

1 reference

12 December 2020

Antimicrobial dosing in obese patients

1 reference

12 December 2020

A simplified dosing method for initiating vancomycin therapy.

1 reference

12 December 2020

Dosage of antituberculous drugs in obese patients.

1 reference

12 December 2020

Obesity as a risk factor in drug-induced organ injury. V. Toxicokinetics of gentamicin in the obese overfed rat

1 reference

12 December 2020

Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique

1 reference

12 December 2020

Cefazolin use in clinically severe obese patients undergoing gastric restrictive surgery

1 reference

12 December 2020

Vancomycin pharmacokinetics in patients with various degrees of renal function

1 reference

12 December 2020

Intravenous ciprofloxacin disposition in obesity

1 reference

12 December 2020

Vancomycin dosing in morbidly obese patients

1 reference

12 December 2020

Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.

1 reference

12 December 2020

Effects of obesity on the cytochrome P450 enzyme system.

1 reference

12 December 2020

Aminoglycoside dosing weight correction factors for patients of various body sizes

1 reference

12 December 2020

Pharmacokinetics of vancomycin in patients with various degrees of renal function

1 reference

12 December 2020

Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria

1 reference

12 December 2020

Variables affecting creatinine clearance prediction

1 reference

12 December 2020

A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects

1 reference

12 December 2020

Surgically affected sulfisoxazole pharmacokinetics in the morbidly obese

1 reference

12 December 2020

Determination of the distribution volume that can be used to calculate the intravenous loading dose

1 reference

12 December 2020

Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight.

1 reference

12 December 2020

Cefamandole distribution in serum, adipose tissue, and wound drainage in morbidly obese patients

1 reference

12 December 2020

Accuracy of estimated creatinine clearance in obese patients with stable renal function in the intensive care unit.

1 reference

12 December 2020

Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides

1 reference

12 December 2020

10.2165/00003088-200038050-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1043112586

0 references

1 reference